Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma.
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Christopher H
CH
Chapman
Department of Radiation Oncology, University of Washington, WA, USA.
Upendra
U
Parvathaneni
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Sue S
SS
Yom
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002277:Carcinoma; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D060828:Induction Chemotherapy; D000077274:Nasopharyngeal Carcinoma; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D050397:Radiotherapy, Intensity-Modulated
antineoplastic agents; antineoplastic combined chemotherapy protocols cell; carcinoma; combined modality therapy; induction therapy; molecular targeted therapy; nasopharyngeal neoplasms; neoadjuvant therapy; sequential therapy; squamous; treatment outcomes